Tourette Disorder
📧 Sign up to get email alerts when something new happens for Tourette Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of Yi-Gan San in children and adolescents with Tourette's Disorder and tic disorders…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD) [Phase 3]
Phase 3 trial assessing efficacy and safety of once-weekly oral aripiprazole in children and adolescents with Tourette's Disorder has comple…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 3]
Phase 3 trial evaluating once-weekly oral aripiprazole for Tourette's disorder in children and adolescents has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder [Phase 4]
Phase 4 trial evaluating long-term oral aripiprazole in pediatric Tourette's Disorder was terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Guanfacine in Children With Tic Disorders [Phase 4]
Phase 4 trial update on guanfacine in children with tic disorders (Tourette Disorder/Tourette Syndrome) has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder [Phase 1, Phase 2]
A proof-of-concept safety study of CPP-109 (vigabatrin) for treatment-refractory Tourette's Disorder has completed phases 1 and 2 with resul…